STOCK TITAN

KDP furnishes Item 7.01, Exhibit 99.1 for Investor Day update

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Keurig Dr Pepper Inc. furnished an Item 7.01 Regulation FD disclosure tied to its investor day. The company provided a press release as Exhibit 99.1 and will post its investor day presentation on its investor relations site at https://investors.keurigdrpepper.com/events-and-presentations.

The press release is titled “KDP Discusses Strategy, Leadership and Financing for Upcoming Transformational Transactions.” Information furnished under Item 7.01 is not deemed “filed” under Section 18 of the Exchange Act unless specifically stated.

Positive

  • None.

Negative

  • None.
0001418135FALSE00014181352025-10-272025-10-27

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 27, 2025
Keurig_Dr_Pepper_logo.jpg
Keurig Dr Pepper Inc.
(Exact name of registrant as specified in its charter)
Delaware001-3382998-0517725
(State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
53 South Avenue, Burlington, Massachusetts 01803
(Address of principal executive offices, including zip code)
877-208-9991
(Registrant's telephone number including area code)
Not Applicable
(Former name or former address if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     Pre-commencement communications pursuant to Rule 13e-14(c) under the Exchange Act (17 CFR 240.13e-14(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).                         

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common stockKDPThe Nasdaq Stock Market LLC





Item 7.01. Regulation FD Disclosure.

On October 27, 2025, Keurig Dr Pepper Inc. (the "Company") issued a press release in connection with its investor day. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated by reference herein. The Company will also make available a copy of its investor day presentation on its investor relations website at https://investors.keurigdrpepper.com/events-and-presentations.

The information presented in this Item 7.01 shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, unless the Company specifically states that the information is to be considered "filed" under the Exchange Act or specifically incorporates it by reference into a filing under the Securities Act or the Exchange Act.

Item 9.01. Financial Statements and Exhibits.
Exhibit No.Description
99.1
Keurig Dr Pepper Inc. Press Release dated October 27, 2025 - "KDP Discusses Strategy, Leadership and Financing for Upcoming Transformational Transactions"
104Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
     
 KEURIG DR PEPPER INC. 
Dated: October 27, 2025
  
 By:/s/ Anthony Shoemaker
  Name:Anthony Shoemaker
  Title:Chief Legal Officer, General Counsel and Secretary


FAQ

What did Keurig Dr Pepper (KDP) disclose in this 8-K?

KDP furnished an Item 7.01 Regulation FD disclosure with an investor day press release as Exhibit 99.1 and noted a presentation will be available on its IR site.

Which Item of Form 8-K applies to KDP’s update?

The disclosure is under Item 7.01 .

Where can I access KDP’s investor day presentation?

KDP will make it available at https://investors.keurigdrpepper.com/events-and-presentations.

What is included as Exhibit 99.1?

Exhibit 99.1 is the press release titled “KDP Discusses Strategy, Leadership and Financing for Upcoming Transformational Transactions.”

When was the press release issued?

The press release was dated October 27, 2025.

What is KDP’s trading symbol and exchange?

KDP’s common stock trades under “KDP” on The Nasdaq Stock Market LLC.

Is the information considered filed under the Exchange Act?

No. Item 7.01 information is furnished, not filed, unless the company specifically states otherwise.
Keurig Dr Pepper Inc

NASDAQ:KDP

KDP Rankings

KDP Latest News

KDP Latest SEC Filings

KDP Stock Data

37.66B
1.29B
4.96%
95.31%
2.34%
Beverages - Non-Alcoholic
Beverages
Link
United States
BURLINGTON